Not all individuals with CLL have to have therapy. Despite all modern innovations, the iwCLL nonetheless suggests watchful observation for individuals with asymptomatic illness.86 This suggestion is predicated on at the least two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituxim